The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

at-agi.com

About New Gene

New Gene applies genetic technology to the field of human precision medicine. It provides accurate and reliable personal genome interpretation reports. It is based in Shanghai, China.

New Gene Headquarter Location

No. 1 Qianwan 1st Road, Qianhai Free Trade Zone Building A

Shanghai, Shanghai,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

New Gene Patents

New Gene has filed 4 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Dog health
  • Knee ligaments
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/19/2021

3/8/2022

Roadsters, Orthopedic surgical procedures, Graphical projections, Light machine guns, Honeycombs (geometry)

Grant

Application Date

2/19/2021

Grant Date

3/8/2022

Title

Related Topics

Roadsters, Orthopedic surgical procedures, Graphical projections, Light machine guns, Honeycombs (geometry)

Status

Grant

Latest New Gene News

Cepheid Adds New Gene Target to SARS-CoV-2 Molecular Test to Account for Variants

May 12, 2022

Save for later NEW YORK – Danaher subsidiary Cepheid announced on Thursday that its Xpert Xpress CoV-2 plus test has received Emergency Use Authorization from the US Food and Drug Administration. The test, a new version of the company's original Xpert Xpress CoV-2 test, includes a new third conserved gene target for the SARS-CoV-2 virus to proactively address the increasing genetic diversity of SARS-CoV-2. The test "optimizes nucleocapsid gene probes to enable consistent virus detection," Cepheid said in a statement. The assay runs on Cepheid's GeneXpert systems and provides positive results in about 20 minutes. It is expected to begin shipping in the US this month. "From the beginning of the pandemic, we have been keenly focused on staying ahead of SARS-CoV-2 genetic drift and have designed our tests in anticipation of current and potential future variants," Cepheid CSO David Persing said in a statement. "The high sensitivity of this test is now especially important for recently announced Test-to-Treat initiatives, for which early detection is important for achieving the best clinical outcomes of antiviral therapies." SARS-CoV-2 variants have caused concerns for some manufacturers of both rapid antigen and molecular tests about the effectiveness of their assays when a new variant emerges. In December, the FDA released a list of molecular tests that may have been affected by the Omicron variant, and companies like Meridian Bioscience have pulled their molecular tests to conduct additional studies to ensure their ability to detect variants.

  • Where is New Gene's headquarters?

    New Gene's headquarters is located at No. 1 Qianwan 1st Road, Qianhai Free Trade Zone, Shanghai.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.